(MENAFN - GlobeNewsWire - Nasdaq) In a laboratory study, antiviral T-cells killed nearly 100% of human liver-derived cancer cells treated with CancerVax's leading LNP-mRNA formulationLehi, Utah, ...
Health
Health
(MENAFN - GlobeNewsWire - Nasdaq) In a laboratory study, antiviral T-cells killed nearly 100% of human liver-derived cancer cells treated with CancerVax's leading LNP-mRNA formulationLehi, Utah, ...